Participants
A total of 884 patients were screened for eligibility between 23 December 2015 and 26 September 2017 across 21 NHS hospitals, of whom 18 participants were enrolled and randomised across 12 hospital. 10 participants were assigned to IVIG treatment, and 8 patients were assigned to placebo. The study flow diagram is shown in Study flow diagram. IVIG, intravenous immunoglobulin.
Baseline characteristics of enrolled participants